Literature DB >> 27050306

Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells.

Shugo Tohyama1, Jun Fujita2, Takako Hishiki3, Tomomi Matsuura4, Fumiyuki Hattori5, Rei Ohno6, Hideaki Kanazawa6, Tomohisa Seki6, Kazuaki Nakajima6, Yoshikazu Kishino6, Marina Okada6, Akinori Hirano7, Takuya Kuroda8, Satoshi Yasuda8, Yoji Sato8, Shinsuke Yuasa6, Motoaki Sano6, Makoto Suematsu4, Keiichi Fukuda9.   

Abstract

Human pluripotent stem cells (hPSCs) are uniquely dependent on aerobic glycolysis to generate ATP. However, the importance of oxidative phosphorylation (OXPHOS) has not been elucidated. Detailed amino acid profiling has revealed that glutamine is indispensable for the survival of hPSCs. Under glucose- and glutamine-depleted conditions, hPSCs quickly died due to the loss of ATP. Metabolome analyses showed that hPSCs oxidized pyruvate poorly and that glutamine was the main energy source for OXPHOS. hPSCs were unable to utilize pyruvate-derived citrate due to negligible expression of aconitase 2 (ACO2) and isocitrate dehydrogenase 2/3 (IDH2/3) and high expression of ATP-citrate lyase. Cardiomyocytes with mature mitochondria were not able to survive without glucose and glutamine, although they were able to use lactate to synthesize pyruvate and glutamate. This distinguishing feature of hPSC metabolism allows preparation of clinical-grade cell sources free of undifferentiated hPSCs, which prevents tumor formation during stem cell therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050306     DOI: 10.1016/j.cmet.2016.03.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  77 in total

Review 1.  Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.

Authors:  Shin Kadota; Yuji Shiba
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

2.  Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts.

Authors:  Hiroyuki Yamakawa; Keiichi Fukuda
Journal:  Stem Cell Investig       Date:  2016-12-09

Review 3.  Technical approaches to induce selective cell death of pluripotent stem cells.

Authors:  Ho-Chang Jeong; Seung-Ju Cho; Mi-Ok Lee; Hyuk-Jin Cha
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

Review 4.  Eight Kinetically Stable but Thermodynamically Activated Molecules that Power Cell Metabolism.

Authors:  Christopher T Walsh; Benjamin P Tu; Yi Tang
Journal:  Chem Rev       Date:  2017-12-22       Impact factor: 60.622

5.  A Method for Cardiac Differentiation, Purification, and Cardiac Spheroid Production of Human Induced Pluripotent Stem Cells.

Authors:  Yuika Morita; Shugo Tohyama; Jun Fujita; Keiichi Fukuda
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Metabolism in pluripotency: Both driver and passenger?

Authors:  Perrine Dahan; Vivian Lu; Robert M T Nguyen; Stephanie A L Kennedy; Michael A Teitell
Journal:  J Biol Chem       Date:  2018-02-20       Impact factor: 5.157

Review 7.  Mitochondria and the dynamic control of stem cell homeostasis.

Authors:  Pawel Lisowski; Preethi Kannan; Barbara Mlody; Alessandro Prigione
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

Review 8.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

Review 9.  A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids.

Authors:  Jonas L Fowler; Lay Teng Ang; Kyle M Loh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-11-19       Impact factor: 5.814

10.  Microenvironmental determinants of organized iPSC-cardiomyocyte tissues on synthetic fibrous matrices.

Authors:  Samuel J DePalma; Christopher D Davidson; Austin E Stis; Adam S Helms; Brendon M Baker
Journal:  Biomater Sci       Date:  2021-01-05       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.